Navigation Links
EntreMed To Raise $10.7 Million In Registered Direct Offering
Date:3/1/2013

d warrants to be issued in this transaction (and the shares of common stock issuable upon exercise of the warrants) has been filed with the Securities and Exchange Commission (the "SEC") and declared effective.  A prospectus supplement relating to the offering will be filed by EntreMed with the SEC.  Copies of the prospectus and prospectus supplement and accompanying prospectuses may be obtained directly from Burrill Securities LLC, Prospectus Department, One Embarcadero Center, Suite 2700, San Francisco, CA 94111, 415-591-5400 or email: wwang@b-c.com.  This announcement is neither an offer to sell nor a solicitation of an offer to buy any securities of EntreMed.  No offer, solicitation or sale will be made in any jurisdiction in which such offer, solicitation or sale is unlawful.

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company employing a drug development strategy primarily in the United States and China to develop targeted therapeutics for the global market.  Its lead compound, ENMD-2076, a selective angiogenic kinase inhibitor, has completed several Phase 1 studies in solid tumors, multiple myeloma, and leukemia, and is currently completing a multi-center Phase 2 study in ovarian cancer.  EntreMed recently announced the initiation of a Phase 2 study of ENMD-2076 in triple-negative breast cancer and the initiation of a Phase 2 study of ENMD-2076 in advanced/metastatic soft tissue sarcoma.  Additional information about EntreMed is available on the Company's web site at www.entremed.com and in various filings with the SEC.

About ENMD-2076

ENMD-2076 is an orally-active, Aurora A/angiogenic kinase inhibitor with a unique kinase selectivity profile and multiple mechanisms of action.  ENMD-2076 has been shown to inhibit a d
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. EntreMed Reports First Quarter 2012 Financial Results
2. EntreMed Announces Initiation Of Phase 2 Trial In Triple-negative Breast Cancer
3. EntreMed Reports Second Quarter 2012 Financial Results
4. Dana-Farber Cancer Institutes Ursula A. Matulonis, MD Article on EntreMeds ENMD-2076 Published in the European Journal of Cancer
5. EntreMed Announces Publication Of Preclinical Results For ENMD-2076 In Triple-negative Breast Cancer
6. PNAS Publishes Preclinical Results of EntreMeds 2ME2 for Multiple Sclerosis
7. EntreMed Announces Initiation Of Phase 2 Trial In Advanced/Metastatic Soft Tissue Sarcoma
8. Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center
9. Xtelligent Media Raises $800K in Funding and Launches EHRintelligence.com
10. National Patient Advocate Foundation Praises Signing of the Delaware Cancer Treatment Access Act into Law
11. BHI Raises Awareness of Hearing Aids as Potential Therapy to Help Quiet "Ringing in the Ears" During National Tinnitus Awareness Week
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... , Dec. 15, 2014   DaVita ... one of the nation,s largest and most innovative ... its business units, DaVita Clinical Research  (DCR) and  ... to further expand its extensive clinical research and ... kidney disease (CKD) and end-stage renal disease (ESRD), ...
(Date:12/13/2014)... DUBLIN , Dec. 11, 2014 Research ... announced the addition of the "Drug Injection ... http://photos.prnewswire.com/prnh/20130307/600769 ... treatment of an expanding list of health conditions, ... options that simplify the administration process and increase ...
(Date:12/13/2014)... Mindray Medical International Limited ("Mindray", NYSE: ... of medical devices worldwide, today announced shareholder resolutions adopted ... Hong Kong on December 10, ... to re-elect incumbent directors Li Xiting and Kern Lim, ... not re-elect Peter Wan as a director. ...
Breaking Medicine Technology:DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 2DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 3DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 4Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4Mindray Announced Shareholder Resolutions Post 2014 Annual General Meeting 2
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... that patients newly diagnosed with obstructive sleep apnea (OSA) ... when beginning continuous positive airway pressure (CPAP) therapy, are ... will be presented at the American Thoracic Society,s International ... a common disorder that leads to multiple adverse effects ...
... CA (May 17, 2009)The COPD Foundation announces launch of ... with WebMD. Development of the Lung Health Check was ... , The Lung Health Check is an educational ... key symptoms and risks of developing lung disease, and ...
... media giant Twitter in a bid to rally support to overcome healthcare red ... need of a heart transplant. , ... Las Vegas, NV (PRWEB) May 17, 2009 -- ... ill brother a much-needed heart transplant has turned into a major grassroots campaign ...
... programs, walking offer ways to keep health on trackDALLAS, May 17 ... cutting back on healthy activities such as eating fresh foods and ... March 2009 by the American Heart Association: , , ... said the economy has affected their ability to take care of ...
... Balance, Normal Walking , ... Haifa, Israel (PRWEB) May ... new meaning for people with Cerebral Palsy who want ... ,The GaitAid Virtual Walker, a nonprescription virtual-reality device, represents a significant ...
... day allow drug delivery to be tailored to an individual ... of California, San Diego School of Medicine, have developed an ... will be published in the May 17 in the advance ... an unbelievable potential to manage cancer and treat it," said ...
Cached Medicine News:Health News:2-week course of sleep aid increases CPAP adherence in OSA patients at 6 months 2Health News:COPD Foundation announces launch of Lung Health Check on WebMD 2Health News:Twitter Boosts CNN Reporter's Fight to Save Her Brother's Life 2Health News:Twitter Boosts CNN Reporter's Fight to Save Her Brother's Life 3Health News:Americans Skimp on Healthy Activities in Bad Economy 2Health News:Americans Skimp on Healthy Activities in Bad Economy 3Health News:New Hope for Walking Normally, Living Better With Cerebral Palsy 2Health News:The future of personalized cancer treatment: An entirely new direction for RNAi delivery 2
... and model 1488 active-fixation leads are among ... the unsurpassed handling advantages, performance, and reliability ... active-fixation leads. Implantable with a 7 F ... Tendril SDX lead is designed to lower ...
... Tendril SDX model 1688 and model 1488 ... extendable/retractable pacing leads, offering the unsurpassed handling ... Jude Medical's line of active-fixation leads. Implantable ... body diameter of the Tendril SDX lead ...
... battery-backed up, microprocessor based, quality instrument that monitors ... and displays a chart on its large panel ... or zoomed into and out of, so that ... months can be seen at one time. ...
... Aegis CheckPoint is an automated, wireless, ... and alert system for refrigerator, freezer, ... chart recorders, data loggers and manual ... on an existing PC and comes ...
Medicine Products: